Molecular Size is Important for the Safety and Selective Inhibition of Intrinsic Factor Xase for Fucosylated Chondroitin Sulfate.

Lufeng Yan,Junhui Li,Danli Wang,Tian Ding,Yaqin Hu,Xingqian Ye,Robert J. Linhardt,Shiguo Chen
DOI: https://doi.org/10.1016/j.carbpol.2017.09.034
IF: 10.723
2017-01-01
Carbohydrate Polymers
Abstract:Fucosylated chondroitin sulfate from sea cucumber Isostichopus badionotus (FCS-Ib) showed potent anticoagulant activities without selectivity. The present study focused on developing safe FCS-Ib oligomers showing selective inhibition of intrinsic factor Xase (anti-FXase) prepared through partial N-deacetylation-deaminative cleavage. The N-deacetylation degree was regulated by reaction time, controlling the resulting oligomer distribution. Structure analysis confirmed the selectivity of degradation, and 12 high purity fractions with trisaccharide-repeating units were separated. In vitro anticoagulant assays indicated a decrease in molecular weight (Mw) dramatically reduced activated partial thromboplastin time (APTT), thrombin time (TT), AT-dependent anti-FIIa and anti-FXa activities, while the oligomers retained potent anti-FXase activity until they fell below 3kDa. Meanwhile, human FXII activation and platelet aggregation were markedly reduced with decreasing Mw and were moderate when under 12.0kDa. Thus, fragments of 3-12.0kDa should be safe and effective as selective inhibitors of intrinsic tenase complex for application as clinical anticoagulants.
What problem does this paper attempt to address?